NF-κB Signaling and Carcinogenesis

Author(s): Takashi Okamoto, Takaomi Sanda, Kaori Asamitsu

Journal Name: Current Pharmaceutical Design

Volume 13 , Issue 5 , 2007

Become EABM
Become Reviewer

Abstract:

NF-κB is an inducible transcription factor that is controlled by the signal activation cascades. NF-κB controls a number of genes involved in immuno-inflammatory responses, cell cycle progression, inhibition of apoptosis and cell adhesion, thus promoting carcinogenesis and cancer progression. Interestingly, some proteins encoded by oncogenes and oncogenic viruses have been shown to be involved in NF-κB activation pathway. In fact, NF-κB is constitutively activated in some cancer and leukemia cells. These findings have substantiated the old concept of the link between chronic inflammation and carcinogenesis. In this review, we have attempted to overview the possible involvement of NF-κB in cancer and discuss the feasibility of anti-cancer strategy with NF-κB and its signaling cascade as novel molecular targets.

Keywords: NF-κB, signal transduction, IKK, cancer, leukemia, transcription, apoptosis

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 5
Year: 2007
Page: [447 - 462]
Pages: 16
DOI: 10.2174/138161207780162944
Price: $65

Article Metrics

PDF: 12